Skip to main content
Chinese Herbal Medicines logoLink to Chinese Herbal Medicines
. 2023 Nov 22;16(3):358–374. doi: 10.1016/j.chmed.2023.07.002

Ethnopharmacology, chemical composition and functions of Cymbopogon citratus

Xiqin Du a,b,1, Meng Zhang a,b,1, Shuping Wang c, Jingyang Li d, Jingze Zhang a,b,, Dailin Liu a,b,
PMCID: PMC11283232  PMID: 39072200

Abstract

Cymbopogon citratus in the gramineous family, also known as lemongrass (LG), is a perennial herb. LG, a drug and food homologous medicine, has a widely recorded medicinal value and food applications. To date, 158 LG compounds have been reported, including terpenoids, flavonoids, phenolic acids. Pharmacological and clinical studies have indicated that LG has antibacterial, neuroprotective, hypoglycemic, hypotensive, anti-inflammatory, and anti-tumor effects. This article reviews LG in ethnopharmacology, chemical composition, pharmacology, food, medicine, and daily chemical applications to provide a basis for the subsequent development of food and medicine.

Keywords: chemical composition, Cymbopogon citratus (DC.) Stapf, drug and food homologous medicine, ethnopharmacology, lemongrass, medicine and food applications

1. Introduction

The perennial herb Cymbopogon citratus (DC.) Stapf in the gramineous family is found throughout tropical and subtropical Asia and is cultivated in South Africa, other nations, and the southern provinces of China (Yang et al., 2020). The whole herb of C. citratus can be used as a traditional Chinese medicine called citronella, also known as lemongrass (LG), used in traditional Chinese medicine. LG, first recorded in the Supplement to Materia Medica (Ben Cao Shi Yi in Chinese) by Zangqi Chen (687–757) during the Tang Dynasty (AD 618–907) of China under the original name Xiangmao in Chinese, has now been included in the Dictionary of Traditional Chinese Medicine (Zhongyao Da Cidian in Chinese). LG is warm, pungent and sweet, and belongs to the lung, stomach and spleen meridians. LG has the effects of expelling wind unblocking collaterals, warming, and relieving pain, dampness and diarrhea. It often treats exogenous wind-cold headaches, rheumatic arthralgia, epigastric cold pain, diarrhea, edema, beriberi, and traumatic injuries (OuYang et al., 2016). Existing research has demonstrated that the main chemical components of LG are terpenoids, flavonoids, phenolic acids, and polysaccharides, which have antibacterial, neuroprotective, antidiabetic, anti-inflammatory, and other pharmacological activities (Umukoro, Ben-Azu, Ajayi, Adebesin, & Emokpae, 2020, Li et al., 2021). LG is commonly used to treat fever, diabetes and hypertension. LG has medicinal value and is used as a seasoning or tea substitute for food (Ekpenyong, Akpan, & Nyoh, 2015, OuYang et al., 2016, Dagupen et al., 2009). LG also has applications in daily chemicals and is often used to make soap, mouthwash. This study reviewed the ethnopharmacology, chemical composition, pharmacology, food, and clinical and daily chemical applications of LG by consulting recent literature to provide a basis for subsequent studies on the homology of medicine and food in LG.

2. Ethnopharmacology

LG has a long history of use as a seasoning in food and medicine to treat diseases in China and elsewhere. LG is frequently used in flavor food because of its distinctive scent. In Southeast Asian countries and China, many foods are often seasoned with LG, such as soup, berries, chicken, pork, and seafood dishes (Dagupen et al., 2009). In addition to food applications, LG is frequently brewed into tea to decrease blood pressure in Brazil, Cuba, and India (Carbajal et al., 1989, Moreira, Bastos, Blank, Alves, & Santos, 2010, Pereira, Marques, Sudo, Kaplan, & Zapata-Sudo, 2013). In Ayurveda, India's traditional treatment system, lemongrass essential oil (LGEO) treats hypertension, fever, stomach disease, and inflammation related to rheumatism, colds and flu (Khan & Ahmad, 2012). In addition, the LG leaf extract and decoction have various therapeutic effects, such as anti-inflammatory, cough-relieving, digestive, antiinfluenza, antipyretic, anti-diabetes and antimalarial (Bertea & Maffei, 2010). In tropical and subtropical countries, LG leaf infusion is widely used to regulate blood sugar, lipid, and fatty blood levels to prevent diabetes, hypertension, and obesity (Borges et al., 2021, Campos et al., 2014, Oladeji, Adelowo, Ayodele, & Odelade, 2019). In China, there are many folk records of the LG. LG, first recorded in the book Supplement to Materia Medica (Ben Cao Shi Yi in Chinese) published in 741 CE, has a warm, brilliant, and sweet taste. It disperses wind, clears collaterals, warms the middle, and relieves pain. It is commonly used to treat cold headaches, fever, abdominal pain, diabetes, hypertension, epilepsy, and anxiety. The Lingnan Medication Collection (Ling Nan Cai Yao Lu in Chinese) recorded that LG water decoction was used to treat headaches by washing the head, dispelling wind, reducing swelling by washing the body and avoiding fishy odors. The decoction was obtained by stir-fried LG and rice and then adding water to treat watery diarrhea. The abdominal pain was relieved using LGEO (Xiang, Wei, Xu, & Xiao, 2017). The Sichuan Traditional Chinese Medicine Chronicle (Sichuan Zhong Yao Zhi in Chinese) reported that bathing with 500 g LG of a water decoction could treat systemic pain caused by wind, cold and dampness. LG also has been recorded in Guangdong Traditional Chinese Medicine (Guangdong Zhong Yao in Chinese), Guizhou Traditional Chinese Medicine (Guizhou Zhong Yao in Chinese), and the National Compilation of Traditional Chinese Medicine (Quan Guo Zhong Cao Yao Hui Bian in Chinese), and has now been included in Chinese Materia Medica (Zhonghua Bencao in Chinese) (Editorial board of Chinese Materia Medica of National Administration of Traditional Chinese Medicine, 1999).

3. Chemical composition

LG has been extensively studied for its chemical components, including volatile oils, flavonoids, phenolic acids, phenylpropanoids, alcohols, esters, aldehydes and alkaloids. Volatile oils are a major component of LG, including monoterpenes, sesquiterpenes, and fewer diterpenes and triterpenes. The active monoterpenes identified were neral, geranial, geraniol, citronellal, and citronellol. At present, 158 chemical constituents of LG have been reported, of which 105 have been isolated and identified (110, 2029, 4355, 6288, 99102, 107134, 137149), and 48 have been analyzed by GC–MS (1119, 3042, 5661, 8998, 103106, 135, 136, 150153).

3.1. Monoterpenes

Monoterpenes are composed of two isoprene units and contain 10 carbon atoms. Monoterpenes, widely distributed in the glands, oil chambers, resin ducts, and other secretory tissues of higher plants, are the significant components of volatile plant oils. A total of 61 monoterpenes were obtained from LG, including 21 acyclic monoterpenes (121), 22 monocyclic monoterpenes (2243), and 18 bicyclic monoterpenes (4461). Li et al. extracted the main components of LGEO from the aboveground part of LG, including citronellal (38.16%), geraniol (19.39%), and citronellol (17.18%), accounting for 75% of the total volatile oil (Li et al., 2021). Vanillin (45.2%) and total aldehyde (32.4%) were isolated from the main components of the essential oil by crushing and distilling LG leaves (Koba et al., 2008). In summary, citronellal (1), geranial (2), neral (5), citronellol (15), and geraniol (16) were the primary monoterpene active ingredients of LG. Table 1 and Fig. 1 showed the monoterpenes in LG in detail.

Table 1.

Monoterpenes (161) isolated from LG.

No. Molecular formulas Compounds References
1 C10H18O Citronellal/β-Citronellal Li et al., 2021
2 C10H16O α-Citral/Citral/Geranial Li et al., 2021
3 C10H16O2 Geranic-acid/Neric acid Ekpenyong, Akpan, & Nyoh, 2015
4 C10H18O Nerol/cis-Geraniol Ekpenyong, Akpan, & Nyoh, 2015
5 C10H16O Neral/β-Citral/cis-Citral Ekpenyong, Akpan, & Nyoh, 2015
6 C10H16 β-Myrcene/Myrcene Ekpenyong, Akpan, & Nyoh, 2015
7 C10H16 β-Ocimene Li et al., 2021
8 C10H18O Linalool/L-linalool Ekpenyong, Akpan, & Nyoh, 2015
9 C10H18O (+)-Linalool/D-linalool Kouame et al., 2015
10 C10H18O Myrcenol Ekpenyong, Akpan, & Nyoh, 2015
11 C10H16 (E)-β-Ocimene Kpoviessi et al., 2014
12 C10H16 (Z)-β-Ocimene Kpoviessi et al., 2014
13 C10H18 2,6-Octadiene, 2,6-dimethyl- Li et al., 2021
14 C10H16 Artemisia triene Li et al., 2021
15 C10H20O Citronellol/β-Citronellol Li et al., 2021
16 C10H18O Geraniol Li et al., 2021
17 C10H18 (-)-Citronellene Li et al., 2021
18 C10H18O Rose oxide Li et al., 2021
19 C10H14O2 Rosefuran epoxide Li et al., 2021
20 C10H14O Perillene Yang et al., 2020
21 C10H18O2 cis-Linaloloxide Barbosa et al., 2008
22 C10H16 D-limonene Li et al., 2021
23 C10H18O α-Terpineol Ekpenyong, Akpan, & Nyoh, 2015
24 C10H16O z-Carveol Kouame et al., 2015
25 C10H14O Dextro-carvone Ekpenyong, Akpan, & Nyoh, 2015
26 C10H16O (-)-trans-Carveol Ekpenyong, Akpan, & Nyoh, 2015
27 C10H18O Terpinen-4-ol Li et al., 2021
28 C10H18O 1,8-Cineole/Cineole/Eucalyptol Li et al., 2021
29 C10H16O α-Cyclocitral Ekpenyong, Akpan, & Nyoh, 2015
30 C10H14 O-Cymene Li et al., 2021
31 C10H14 p-Cymene Kpoviessi et al., 2014
32 C10H16 β-Terpinene Li et al., 2021
33 C10H16 γ-Terpinene Li et al., 2021
34 C10H16 Terpinolene/α-Terpinolene Li et al., 2021
35 C10H18O p-Menthone/1-Menthone Li et al., 2021
36 C10H18O Isopulegol/L-isopulegol Li et al., 2021
37 C10H20O2 7-Hydroxymenthol Zhang et al., 2014
38 C10H16O cis-p-Mentha-2,8-dienol Kpoviessi et al., 2014
39 C10H16O α-Phellandren-8-ol Kpoviessi et al., 2014
40 C10H18O L-α-Terpineol Li et al., 2021
41 C10H12O Anethole Li et al., 2021
42 C10H16O p-Mentha-1(7),8(10)-dien-9-ol Kpoviessi et al., 2014
43 C10H16O trans-Chrysanthemal Ekpenyong, Akpan, & Nyoh, 2015
44 C10H16 α-Pinene Kouame et al., 2015
45 C10H16 Camphene Kouame et al., 2015
46 C10H16 Tricyclene Kouame et al., 2015
47 C10H14O Verbenone Kouame et al., 2015
48 C10H16O Myrtenol Yang et al., 2020
49 C10H16O Myrtanal Kouame et al., 2015
50 C10H18O Borneol Kouame et al., 2015
51 C10H16O α-Pinene oxide Ekpenyong, Akpan, & Nyoh, 2015
52 C10H16O β-Pinene oxide Ekpenyong, Akpan, & Nyoh, 2015
53 C10H16O Sabinol Kouame et al., 2015
54 C10H16 α-Thujene Li et al., 2021
55 C10H16 3-Carene Kouame et al., 2015
56 C10H16O trans-3(10)-Caren-2-ol Kpoviessi et al., 2014
57 C10H18 Pinane Li et al., 2021
58 C10H16 β-Pinene Kpoviessi et al., 2014
59 C10H16 1R-α-Pinene Li et al., 2021
60 C10H18 Isocamphane Li et al., 2021
61 C10H16O cis-Verbenol Kpoviessi et al., 2014

Fig. 1.

Fig. 1

Chemical structures of monoterpenes from LG.

3.2. Sesquiterpenes

Sesquiterpenes contain three isoprene units with chains, rings, and other skeletal structures. A total of 37 sesquiterpenes were obtained from LG, including one sesquiterpene chain (62) and 36 cyclic sesquiterpenes (6398). β-Elemene (96) is an isomer of elemene, a lipid-soluble sesquiterpene, and an active component of LG with potential antineoplastic and chemopreventive activities. Sesquiterpenes from LG are shown in Table 2 and Fig. 2.

Table 2.

Sesquiterpenes (6298) isolated from LG.

No. Molecular formulas Compounds References
62 C15H24 α-Farnesene Ekpenyong, Akpan, & Nyoh, 2015
63 C15H24 γ-Muurolene Ekpenyong, Akpan, & Nyoh, 2015
64 C15H24 α-Muurolene/Muurolene Ekpenyong, Akpan, & Nyoh, 2015
65 C15H24 δ-Cadinene Ekpenyong, Akpan, & Nyoh, 2015
66 C15H24 γ-Cadinene Kouame et al., 2015
67 C15H24 Isogermacrene D Kouame et al., 2015
68 C15H24 Germacrene-D Ekpenyong, Akpan, & Nyoh, 2015
69 C15H26O epi-Cubenol Kouame et al., 2015
70 C15H26O α-Cadinol Avoseh et al., 2015
71 C15H26O t-Cadinol Ekpenyong, Akpan, & Nyoh, 2015
72 C15H26O t-Muurolol Ekpenyong, Akpan, & Nyoh, 2015
73 C15H26O Isointermedeol Yang et al., 2020
74 C15H26O β-Eudesmol Ekpenyong, Akpan, & Nyoh, 2015
75 C15H26O Selina-6-en-4-ol Avoseh et al., 2015
76 C15H24 α-Selinene Ekpenyong, Akpan, & Nyoh, 2015
77 C15H24 Valencene Ekpenyong, Akpan, & Nyoh, 2015
78 C15H26O Viridiflorol Ekpenyong, Akpan, & Nyoh, 2015
79 C15H26O Elemol Ekpenyong, Akpan, & Nyoh, 2015
80 C15H26O α-Elemol Ekpenyong, Akpan, & Nyoh, 2015
81 C15H24 Zingiberene Kouame et al., 2015
82 C15H24 β-Sesquiphellandrene Ekpenyong, Akpan, & Nyoh, 2015
83 C15H24O β-Caryophyllene oxide Kouame et al., 2015
84 C15H24 β-Caryophyllene Kouame et al., 2015
85 C15H24 α-Gurjunene Ekpenyong, Akpan, & Nyoh, 2015
86 C15H24 Aromandendrene Kouame et al., 2015
87 C15H24 Humulene/α-Humulene Ekpenyong, Akpan, & Nyoh, 2015
88 C15H24 trans-α-Bergamotene Barbosa et al., 2008
89 C15H24 α-Santalene Li et al., 2021
90 C15H26O Juniper camphor Barbosa et al., 2008
91 C15H24 δ-EIemene Li et al., 2021
92 C15H24 α-Cubebene Li et al., 2021
93 C15H24 β-Bourbonene Kpoviessi et al., 2014
94 C15H24 Cuparene Barbosa et al., 2008
95 C15H24 (+)-β-Elemene Li et al., 2021
96 C15H24 (-)-β-Elemene/β-Elemene Li et al., 2021
97 C15H26O Torreyol Barbosa et al., 2008
98 C15H26O Eudesm-7(11)-en-4-ol Kpoviessi et al., 2014

Fig. 2.

Fig. 2

Chemical structures of sesquiterpenes from LG.

3.3. Diterpenes and triterpenes

Eight diterpenes and triterpenes were identified in LG. Diterpenes included two chains of diterpenes (99 and 100) and one cyclic diterpene (101). Five triterpenes (102106) were cyclic. Carnosic acid (101) is an abietane diterpene, an ability-8,11,13-triene substituted by hydroxy groups at positions 11 and 12 and a carboxy group at position 20. The diterpenes and triterpenes isolated from LG are shown in Table 3 and Fig. 3.

Table 3.

Diterpenes and triterpenes (99106) isolated from LG.

No. Molecular formulas Compounds References
99 C20H40O Phytol Santos Serafim Machado et al., 2015
100 C22H42O2 Phytol acetate Santos Serafim Machado et al., 2015
101 C20H28O4 Carnosic acid Barbosa et al., 2008
102 C30H50O Cymbopogonol Yang et al., 2020
103 C30H50O Cymbopogone Crawford, Hanson, & Koker, 1975
104 C30H50O Filican-3-one Crawford, Hanson, & Koker, 1975
105 C30H50O D:A-Friedoursan-3-one Yang et al., 2020
106 C30H50O Friedelin Crawford, Hanson, & Koker, 1975

Fig. 3.

Fig. 3

Chemical structures of diterpenes and triterpenes from LG.

3.4. Flavonoids

Only 10 flavonoids, including eight flavonoids (107, 110116) and two flavonols (108 and 109), have been identified thus far in research on flavonoids in LG. LG contains six flavonoid glycosides in LG, including three C6-glycosides, one C8-glycoside, one O3-glycoside, and one O7-glycoside. Detailed information on the flavonoids in LG is shown in Table 4 and Fig. 4.

Table 4.

Flavonoids (107116) isolated from LG.

No. Molecular formulas Compounds References
107 C15H10O5 Apigenin Ekpenyong, Akpan, & Nyoh, 2015
108 C15H10O6 Kaempferol Ekpenyong, Akpan, & Nyoh, 2015
109 C15H10O7 Quercetin Ekpenyong, Akpan, & Nyoh, 2015
110 C15H10O6 Luteolin Ekpenyong, Akpan, & Nyoh, 2015
111 C22H22O11 Isoscoparin Ekpenyong, Akpan, & Nyoh, 2015
112 C22H22O11 Swertiajaponin Ekpenyong, Akpan, & Nyoh, 2015
113 C21H20O11 Luteolin-7-O-glucoside Avoseh et al., 2015
114 C21H20O11 Isoorientin Cheel et al., 2005
115 C21H20O11 Orientin Ekpenyong, Akpan, & Nyoh, 2015
116 C27H30O16 Rutin Meabed, Abou-Sreea, & Roby, 2018

Fig. 4.

Fig. 4

Chemical structures of flavonoids from LG.

3.5. Phenolic acids

Phenolic acids are metabolic component containing phenolic hydroxyl and carboxylic acids, with only one benzene ring in the molecule. Based on their carbon skeleton structures, phenolic acids can be divided into hydroxybenzoic acid derivatives (C6–C1 type) and hydroxycinnamic acid derivatives (C6–C3 type). Seven phenolic acids were isolated and identified from LG, of which two (117 and 118) were hydroxybenzoic acid derivatives, and five (119123) were hydroxycinnamic acid derivatives. Details of the phenolic acids are shown in Table 5 and Fig. 5.

Table 5.

Phenolic acids (117123) isolated from LG.

No. Molecular formulas Compounds References
117 C7H6O3 p-Hydroxybenzoic acid Tapia et al., 2007
118 C7H6O5 Gallic acid Barbosa et al., 2008
119 C9H8O3 p-Coumaric acid/4-Hydroxycinnamic acid Ekpenyong, Akpan, & Nyoh, 2015
120 C10H10O4 Ferulic acid Barbosa et al., 2008
121 C9H8O4 Caffeic acid Ekpenyong, Akpan, & Nyoh, 2015
122 C16H18O9 Chlorogenic acid Ekpenyong, Akpan, & Nyoh, 2015
123 C16H18O9 Neochlorogenic acid Tapia et al., 2007

Fig. 5.

Fig. 5

Chemical structures of phenolic acids from LG.

3.6. Polysaccharides

More researchers have focused on polysaccharides in recent years because of their widespread use in healthy foods and medications. The biological effects of LG polysaccharides include immunomodulatory and anti-tumor activities. The polysaccharides in LG include the water-soluble polysaccharides HWSPs (124), CCP (125), and CCF (126), and the acidic polysaccharides F1 (127) and F2 (128). FTIR analysis further confirmed that HWSP is a polysaccharide containing proteins and uronic acid (Thangam, Suresh, & Kannan, 2014). Unlike HWSPs, neither CCP nor CCF contains proteins, while CCP contains less uronic acid. Analysis of the monosaccharide composition by HPLC showed that CCP was composed of glucose, rhamnose, ribose, galactose, arabinose, xylose, and mannose, with a molar ratio of 6.17:5.90:3.40:2.92:2.31:1.63:1.00 (Bao, Yuan, Wang, Fan, & Lan, 2015, Chen et al., 2022). F1 and F2 are the polysaccharide fractions containing uronic acid. F1 and F2 comprise xylose, glucose, galactose and mannose, with xylose as the main monosaccharide skeleton (Thangam, Sathuvan, & Kannan, 2014).

3.7. Other compounds

In addition, 30 compounds (129158) were isolated from LG, including phenols, phenylpropanoids, esters, alcohols, aldehydes, ketones, alkaloids, and amino acids (Table 6 and Fig. 6).

Table 6.

Other compounds (129158) isolated from LG.

NO. Molecular formulas Compounds References
129 C6H6O2 Catechol Ekpenyong, Akpan, & Nyoh, 2015
130 C6H6O2 Hydroquinone Avoseh et al., 2015
131 C6H6O3 Pyrogallol/Pyrogallic acid Barbosa et al., 2008
132 C8H8O3 Vanillin Yang et al., 2020
133 C10H12O2 Chavibetol/M-Eugenol Li et al., 2021
134
C10H12O2 Isoeugenol Kouame et al., 2015
135 C10H12O2 Eugenol Yang et al., 2020
136 C11H14O2 Methyl eugenol Yang et al., 2020
137 C12H16O3 Elemicin Ekpenyong, Akpan, & Nyoh, 2015
138 C9H8O2 Cinnamic acid Barbosa et al., 2008
139 C12H20O2 Neryl acetate Kouame et al., 2015
140 C11H18O2 Neryl formate Li et al., 2021
141 C12H20O2 Geranyl acetate Li et al., 2021
142 C11H18O2 Geranyl formate Kouame et al., 2015
143 C21H42O2 Eicosanoic acid methyl ester Santos Serafim Machado et al., 2015
144 C18H27NO3 Capsaicin Yang et al., 2020
145 C8H14O 6-Methyl-5-hepten-2-one Ekpenyong, Akpan, & Nyoh, 2015
146 C11H22O Methyl-n-nonyl-ketone Ekpenyong, Akpan, & Nyoh, 2015
147 C13H20O β-Ionone Yang et al., 2020
148 C16H32O2 Palmitic acid Santos Serafim Machado et al., 2015
149 C8H16O Octanal Kpoviessi et al., 2014
150 C5H9NO4 Glutamic acid Tapia et al., 2007
151 C5H6O2 Furfurol Ekpenyong, Akpan, & Nyoh, 2015
152 C9H18O Nonanal Lorenzetti, Souza, Sarti, Santos Filho, & Ferreira, 1991
153 C10H20O Decanal Li et al., 2021
154 C8H14O 1-Octyn-3-ol Ekpenyong, Akpan, & Nyoh, 2015
155 C9H16O Melonal Li et al., 2021
156 C10H18O Nopol Kpoviessi et al., 2014
157 C9H18 1-Isopropyl-3-methylcyclopentane Li et al., 2021
158 C17H28ClNO 8-Hmpat Li et al., 2021

Fig. 6.

Fig. 6

Other compounds isolated from LG.

4. Pharmacology

The effectiveness of LG has been documented in several books. According to Guangdong Traditional Chinese Medicine, LG can treat dizziness and phlegm caused by wind, and its water decoction has been used to treat heartache after drinking, owing to its anti-inflammatory and analgesic effects. The Guizhou Folk Medicine (Guizhou Minjian Yaowu in Chinese) also mentions that LG water decoction can alleviate stomach aches, which affects the digestive tract. Other biological functions of LG have also been found in contemporary pharmacological studies, including antibacterial, neuroprotective, anti-diabetes, antioxidant, free radical scavenging, anti-tumor, and immunomodulatory effects (Fig. 7).

Fig. 7.

Fig. 7

Modern pharmacological effects of LG.

4.1. Antimicrobial effect

Lemongrass essential oil (LGEO) exhibits good antibacterial activity and expressed inhibitory effects against various bacteria and fungi. These included gram-negative bacteria (Serratia marcescens, Escherichia coli, Pseudomonas aeruginosa, and Chromobacterium violaceum), gram-positive bacteria (Staphylococcus aureus and Staphylococcus albus), and fungi (Candida albicans and Candida tropicalis) (Fig. 8). The antibacterial activity of LGEO is mainly attributed to the presence of active components, including citral, citronellal, citronellol, linalool, and geraniol (Bakkali et al., 2008, Ekpenyong, Akpan, & Nyoh, 2015).

Fig. 8.

Fig. 8

Antimicrobial effect of LG.

Bacteriostasis experiments indicated that when the concentration of LGEO diluted in methanol was 25%, the inhibition rates of LGEO against S. marcescens MG1, S. marcescens H30, E. coli, S. aureus, P. aeruginosa, and C. violaceum were 71.30%, 68.10%, 58.85%, 73.49%, 55.36%, and 100%, respectively. The inhibitory activity of LGEO against gram-negative bacteria was higher than that against gram-positive bacteria, and the inhibition rate increased as the LGEO content increased (Yang et al., 2021). Furthermore, S. albus and C. albicans were all refrained by LGEO, with minimum inhibitory concentrations (MIC) of 1.188%−2.375% and 2.375%−4.75% and minimum bactericidal concentrations (MBC) of 2.375%−4.75% and 4.75%−9.5% (Niu et al., 2020). Sahal et al. determined the MIC and MBC of LGEO against three types of C. tropicalis: C. tropicalis T26, C. tropicalis U71, and C. tropicalis V89. The MIC were 0.2%, 0.1% and 0.39%, and the MBC were 0.39%, 0.1% and 0.39% (Sahal et al., 2020).

A study of the inhibitory effect of LGEO on C. albicans activity in vitro indicated that the gas-phase antibacterial effect was significantly better than the liquid contact effect. We found that the structure and surface properties of C. albicans changed notably after treatment with LGEO. The degree of cell atrophy and surface property changes caused by vapor-phase fumigation are more significant than those caused by liquid contact (Tyagi & Malik, 2010). Ergosterol is the most abundant sterol component in fungal membranes. It is the vital to the structural integrity of the cell membrane and, therefore, is the main target of most available antifungal drugs. The transcriptional regulator gene (ERG), which converts lanolin to ergosterol, is downregulated by citronellol, geraniol, and citronellol, thereby disrupting the fungal cell membrane integrity. Moreover, Citronella disturbs membrane stability by increasing fungal hypersensitivity to membrane disruptors, decreasing ergosterol levels, and reducing glucose-induced H+ extrusion (OuYang et al., 2021).

4.2. Neuroprotective effect

Numerous studies have demonstrated the neuroprotective properties of LGEO, including its anti-neurotoxicity, anti-convulsant, hypnotic, and anti-anxiety effects. The primary mechanisms by which LGEO exerts its neuroprotective effects include inhibition of oxidative stress and inflammatory responses, alteration of seizure thresholds or prevention of the spread of seizures, reduction of central activity, and regulation of the GABAA receptor-benzodiazepine complex.

Madi et al. investigated the effects of aqueous LG extracts (125, 250, and 500 mg/kg) and ethanolic extracts (125, 250, and 500 mg/kg) on AlCl3-induced Alzheimer's disease (AD) in rats. Oral administration of LG aqueous extract (250 and 500 mg/kg) and LG ethanolic extract (125 mg/kg) significantly down-regulated AlCl3-induced elevated levels of Aβ (78.38%, 75.51%, and 81.34%), tau protein (86.44%, 79.24%, and 67.80%), malondialdehyde (83.58%, 76.75%, and 80.63%), nuclear factor-kappaB (NF-κB) (74.01%, 63.61%, and 80.82%) and IL-6 (65.82%, 41.69%, and 79.89%) in rats. By decreasing oxidative stress and inflammatory indicators, LG extract reduced AlCl3-induced neurotoxicity in rats. This effect may be partly attributed to the high content of caffeic acid and isoorientin (Madi, Choucry, El-Marasy, Meselhy, & El-Kashoury, 2020).

Adult zebrafish were pretreated, soaked in four samples of C. citratus essential oil (EO), aqueous ethanol extract of LG leaves (E1), citral (CIT), and geraniol (GER), and then exposed to a pentylenetetrazole (PTZ) solution to evaluate the anti-convulsant properties of LG. The latent time of the initial convulsion was longer in zebrafish treated with EO (20 mg/L), E1 (3 mg/L), CIT (20 mg/L), GER (20 mg/L), and CIT + GER (5 mg/L) than in the model group. Evaluation of oxidative stress markers in zebrafish brain homogenates showed that the model group had significantly higher levels of malondialdehyde (MDA) and nitric oxide (NO) than the control group. In contrast, glutathione (GSH) and catalase (CAT) levels were remarkably reduced. Compared to the model group, the administration group effectively reduced MDA and NO levels, increased GSH levels, and restored CAT enzyme activity. It has been proven that LG engages in antioxidant pathways that contribute to neuroprotection (Hacke, Miyoshi, Marques, & Pereira, 2021). Another study evaluated the epileptic seizures induced by pentylenetetrazole in mice. Mice treated with LGEO were protected against seizure episodes, reducing the occurrence of seizures to 40% in mice treated with 0.5 g/kg and 20% in mice treated with 1.0 g/kg. LGEO may be effective by changing the course of seizures, meddling with seizure thresholds, or preventing seizures from spreading (Blanco, Costa, Freire, Santos, & Costa, 2009).

LG not only exerts effects on the nervous system through antioxidant and anti-inflammatory mechanisms but is also considered an enzyme inducer with central inhibitory activity. After LGEO therapy, pentobarbital sodium elicited decreased sleep latency and increased sleep duration, indicating that LGEO may achieve hypnotic effects by obstructing central nervous system activity. It was discovered that the LGEO group (1.0 g/kg) significantly increased the frequency of open-arm entry and the amount of time spent in a bright room using an elevated labyrinth and a light/dark box program to measure anxiety activity (Blanco, Costa, Freire, Santos, & Costa, 2009). Further studies have shown that the anxiolytic effect of LGEO is related to its regulatory effect on the GABAA-Prozac receptor complex (Yang et al., 2020).

4.3. Antidiabetic effect

According to these studies, LG has an antidiabetic effect, effectively reduces endoplasmic reticulum (ER) stress-induced hyperglycemia, and lowers weight, triglyceride, total cholesterol, and low-density lipoprotein levels in diabetic rats. Rutin is an effective ingredient for reducing blood sugar levels in LG.

ER stress plays a vital role in diabetes pathogenesis. ER stress in rats was induced by streptozotocin (STZ), and rats were treated with LG methanolic leaf extract (100, 200, and 400 mg/kg). Fasting blood glucose (FBG), ER stress-related genes, antioxidants, and pro-inflammatory genes were measured as indicators in diabetic rats. The findings revealed that the methanolic extract of LG significantly decreased FBG levels in diabetic rats and down-regulated GRP78, CHOP, ATF4, TRB3, PERK, IRE1, TNF-α gene manifestation, and up-regulated AhR, Nrf2 gene manifestation. Consequently, STZ-induced ER stress was reduced by LG leaf methanolic extract (100 and 400 mg/kg) through the downregulation of GRP78 and upregulation of NRF2 signaling, thus achieving the effect of reducing blood glucose (Elekofehinti, Onunkun, & Olaleye, 2020).

Ewenighi et al. administered LG extract (1.5 mg/100 g) to diabetic rats for four weeks. There was a prominent increase in high-density lipoprotein levels and a decrease in body weight and blood sugar, triglyceride, total cholesterol, and low-density lipoprotein levels compared to controls (Ewenighi et al., 2013). Meabed et al. determined that the flavonoid content in LG aqueous extract and rutin accounted for 1.843% of the total extract (Meabed, Abou-Sreea, & Roby, 2018). An STZ-nicotinamide rat model of type 2 diabetes showed that rutin possessed hypoglycemic qualities and protected against diabetes complications. The α-glucosidases and α-amylase were blocked by rutin (50 or 100 mg/kg), which can lessen the absorption of carbohydrates in the small intestine. β-Cells were stimulated by rutin (50 mg/kg) to secrete insulin, thus protecting Langerhans islets from deterioration, promoting tissue glucose uptake, and inhibiting gluconeogenesis in the liver (Ghorbani, 2017).

4.4. Anti-inflammation

Francisco et al. evaluated the anti-inflammatory effects of several citronella extract ingredients and discovered that tannins, flavonoids, and phenolic acids have substantial pharmacological effects. Chlorogenic acid (CA), the primary phenolic acid in LG, is a crucial anti-inflammatory substance. It was identified that the expression of cytokines was inhibited by chlorogenic acid through the nuclear factor-κB (NF-κB) pathway, and it was the first time to inhibit the expression of cytokines through the ubiquitin proteasome system. Moreover, CA may exert anti-inflammatory effects by suppressing the activation of p38 mitogen-activated protein kinase (p38 MAPK) and c-Junnh2-terminal kinase (JNK) (Francisco et al., 2013, Francisco et al., 2011, Shen et al., 2021). Recent studies have shown that the natural flavonoid quercetin can reduce the symptoms of multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus in both human and animal models. The levels of neurotoxic and pro-inflammatory mediators in patients with multiple sclerosis were suppressed by quercetin, thereby preventing NF-κB activation. Quercetin also enhances intestinal integrity and hepatic antioxidant capacity, modulates the ERK1/2-FKBP and RXR-STAT3 pathways, increases serum glutathione levels, and inhibits hydrogen peroxide-induced oxidative stress (Francisco et al., 2013, Francisco et al., 2011, Shen et al., 2021). Furthermore, ferulic acid exerts anti-inflammatory effects. The anti-inflammatory effect of ferulic acid (100 mg/kg) was mainly related to the levels of peroxisome proliferator-activated receptor gamma (PPARγ), cell adhesion molecules (CAM), and NF-κB and p38 MAPK signaling pathways. This mechanism is illustrated in Fig. 9 (Li et al., 2021).

Fig. 9.

Fig. 9

Anti-inflammation and antioxidant effects of citral and ferulic acid in LG.

Citral is one of the main monoterpenoids in LGEO, which activates peroxisome proliferator-activated receptor (PPAR)- α and γ. Citral inhibits NF-κB activation, and cyclooxygenase-2 (COX-2) communication was inhibited by citral. Campos et al. investigated the role of citral in an experimental mouse model of acute inflammation and nociceptive hypersensitivity. Citral (50, 100, or 300 mg/kg) markedly inhibited carrageenan-induced paw edema [(57 ± 2.0)%, (70 ± 4.0)%, and (66 ± 3.5)%] and effectively reduced thermal ectopic pain [(62 ± 8.0)%, (80 ± 6.0)%, and (62 ± 3.0)%]. Citral modulates the TLR4 and TLR2/Dectin-1 signaling pathways (Campos et al., 2019, Goncalves et al., 2020). This mechanism is illustrated in Fig. 9.

4.5. Antioxidant and free radical scavenging effects

Studies have shown that antioxidants and free radical scavengers are associated with the prevention of atherosclerosis, heart disease, cancer, arthritis, and other pathologies involving reactive oxygen species (ROS) or free radicals (Middleton, Kandaswami, & Theoharides, 2000). The copper-induced low-density lipoprotein oxidation test showed that LG significantly inhibited Cu2+ induced low-density lipoprotein oxidation. The production of active oxidants in human umbilical vein endothelial cells attacked by high D-glucose (60% inhibition), hydrogen peroxide (80% inhibition), or oxidized low-density lipoprotein (55% inhibition) decreased LG by 10 and 100 μg/mL (Campos et al., 2014). The polyphenol-rich components of LG, such as chlorogenic acid, caffeic acid, and ferulic acid, have strong antioxidant properties (Khan et al., 2016). The molecular pathway underlying the antioxidant effects of ferulic acid is shown in Fig. 9 (Li et al., 2021).

The 1,1-diphenyl-2-pyridyl propionyl hydrazide (DPPH) assay indicated that the semi-inhibitory concentration (IC50) values for the dichloromethane, ethyl acetate (EtOAc), and methanol extracts of LG were 152, 131, and 41 µg/mL, respectively. The results demonstrated that the LG methanol extract had high antioxidant and free-radical scavenging activity (Cheel et al., 2005).

4.6. Antitumor and immunomodulatory effects

LG was found that had anti-tumor activity and an apparent inhibitory effect on a variety of cancer cells, which was predominantly attributed to its polysaccharide substances (Yang et al., 2020). Mice inoculated with sarcoma 180 (S180) cells were intraperitoneally injected with LG polysaccharide extract (CCPS), and the effects of CCPS on tumor growth, thymus and spleen weights, spleen cell proliferation, and cytokine secretion in tumor-bearing mice were measured seven days later. Mice in the model control group inoculated with S180 gradually experienced negative symptoms, including anorexia, weariness, lethargy, and black hair, due to the rapid growth of tumors. However, these symptoms were markedly diminished in mice treated with CCPS. With dose-dependent inhibition rates of 14.8%, 21.6%, 26.4%, and 37.8% at dosages of 30, 50, 100, and 200 mg/(kg·d), respectively, CCPS considerably slowed tumor growth. At the highest dose of 200 mg/(kg·d), the thymus and spleen weights, splenocyte proliferation, and cytokine secretion in tumor-bearing mice were significantly increased. However, CCPS was not toxic to S180 cells and was hardly observed. Therefore, CCPS exhibited anti-tumor activity in vivo, which may be achieved through immune enhancement rather than direct cytotoxicity (Bao, Yuan, Wang, Fan, & Lan, 2015).

LG had a strong anti-colon cancer effect, in which the ethanol extract induced colon cancer cell apoptosis in a time- and dose-dependent manner without damaging healthy cells in vitro and effectively inhibited the growth of xenotransplantation of colon cancer in mice at 16 mg/kg. Additionally, feeding LG ethanol extracts to APCmin/+ transgenic mice reduced intestinal tumors, indicating its preventive potential (Ruvinov et al., 2019). Gallic acid is an active ingredient of LG used in the fight against colon cancer. In the treatment of colorectal cancer, the combination of gallic acid and anti-PD-1 antibody not only weakened PD-L1/PD-1 signal transduction and reduced Foxp3 stability, but it also encouraged the CD8+ T cell production of IFN-γ and limited tumor development (Deng et al., 2022).

As an anticancer agent, luteolin can fight various human malignant tumors, such as lung, glioblastoma, breast, prostate, and colon cancers. Luteolin can also reverse the epithelial-mesenchymal transition (EMT) through a mechanism involving cytoskeleton shrinkage, induction of the epithelial biomarker E-cadherin indication, and down-regulation of the mesenchymal biomarkers N-cadherin, snail, and vimentin (Imran et al., 2019). Carnosic acid has been extensively studied in oncology both in vivo and in vitro, and has been shown to have anticancer effects against colorectal, leukemia, kidney, brain, and hepatic cancers (Bahri et al., 2016). Kim et al. indicated a decrease in the viability of human colon cancer HCT116 cells treated with carnosic acid (20 to 100 mmol/L). It triggers HCT116 cell apoptosis via ROS generation, p53 and Bax induction, Caspase3–9 activation, poly (ADP-ribose) polymerase (PARP) cleavage, and STAT3 signaling pathway inhibition (Kim et al., 2016).

4.7. Effect on digestive system

LG has good therapeutic effects on digestive system diseases, including anti-gastric ulcers and liver protection. LGEO and vanillin accelerated the process of gastric healing and demonstrated that the production of gastric mucus was involved in this process. Moreover, geraniol did not inhibit the H+- and K+-ATPase activity, although it showed a gastric healing effect at a lower dose (1 μg/mL). In contrast, the H+- and K+-ATPase activities were curbed with 100 μg/mL citral, which may be related to their gastric protective effects but cannot ensure the characteristics of gastric healing. Therefore, LGEO and geraniol can potentially gastric ulcers, and citral can effectively prevent gastric injury (Sagradas et al., 2015, Venzon et al., 2018).

Alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (γGT) were commonly used indicators for evaluating hepatoprotective effects. Mice with paracetamol (APAP)-induced acute liver injury were orally administered LGEO (125 and 500 mg/kg) for one week. Pretreatment with 125 and 500 mg/kg LGEO significantly reduced the levels of serum markers ALT (95.35% and 97.70%, respectively), AST (91.22% and 94%, respectively), ALP (65.79% and 79.46%, respectively) and γGT (42.63% and 42%, respectively) compared to the APAP group. These results indicated that LGEO exerted protective effects against APAP-induced hepatotoxicity (Uchida et al., 2017).

5. Safety evaluation

The toxicities of LG ethyl acetate, chloroform distillate, essential oils, and pure citral and geraniol components were assessed using Artemia salina and human blood cells. Ethyl citrate and chloroform fractions, essential oils, citral, and geraniol were toxic to A. salina and human blood cells and could induce changes in the erythrocyte membrane at higher concentrations. Therefore, it is necessary to study these fractions to further determine the phytochemicals related to the observed cytotoxicity and to use an in vivo model for exploration. Thus, LG can be used in clinical practice (Hacke et al., 2022).

In a safety assessment experiment, healthy volunteers consumed herbal tea (called Abafador in Brazil) prepared from the dried leaves of LG. After a single dose or oral administration for two weeks, the Abafador had no change in serum glucose, urea, creatinine, cholesterol, triglycerides, lipids, total bilirubin, indirect bilirubin, glutamic-oxaloacetic transaminase (GOT), glutamic-pyruvic transaminase (GPT), alkaline phosphatase, total protein, albumin, lactate dehydrogenase (LDH), and creatine phosphokinase (CPK). Urine analysis, electroencephalographic (EEG), and electrocardiographic (ECG) were normal. Some volunteers showed a slight increase in direct bilirubin and amylase levels; however, no clinical manifestations were observed. These results declared that the LG used in Brazilian folk medicine is non-toxic to the human body (Leite et al., 1986).

6. Applications

6.1. Food applications

LG is frequently used as a flavoring agent in daily life because of its distinctive aromatic flavor and three primary uses (Fig. 10). First, fresh LG stems and leaves were seasoned to eliminate fishy odor, flavor, and oil from chicken, fish, and beef dishes and to improve the freshness and flavor of shellfish and shrimp. LG is also cooked with asparagus, onions, and peas. Second, the LG stems and leaves were processed to produce various flavored products, including LG powder, sauce, salad dressing, hot pot sauce, and cooking oil, which were used to complement the flavor and remove the fishy smell of the foods. Third, when LGEO is extracted as a food additive, it is mainly used for flavoring cakes, honey, milk tea, and other staple and non-staple foods (Qiu et al., 2020).

Fig. 10.

Fig. 10

Applications of LG in food, clinic and daily chemical.

In foreign countries, LG is used as a seasoning and health tea. Tom Yum is a daily and distinctive food in Southeast Asia. LG, as an indispensable seasoning, has played a role in increasing the brilliant flavor and removing the fishy smell of shrimp and crabs. In Thailand, Malaysia, Vietnam, Brazil, India, and other countries, LG has been developed into a healthy tea to reduce blood pressure. Similarly, many LG-growing provinces in China often convert LG into tea drinks, which have the effects of stomach ventilation and awakening the brain. In addition, LG is often added to fish soup, mutton soup, and hot pot condiments in China because of its pungent flavor. In summer, LG is also added to porridge to prevent heatstroke and improve appetite. The Dai people, an ethnic minority in China, often bind marinated crucian carp and tilapia to LG and slowly bake them with charcoal over a low fire until the fish are ripe. Food tastes fresh, tender and brilliant.

Furthermore, LG can be used as a natural antibacterial agent for food preservation. LGEO has a noticeable inhibition effect on vegetable and fruit decay caused by various molds, such as Botrytis cinema, Penicillium expansum, Rhizopus stolonifer, Colletotrichum musae, and Colletotrichum gloeosporioides (Arrebola et al., 2010).

6.2. Clinical applications

LG, as a drug and food homologous medicine, is widely used in the food industry and has a long history of clinical application. It can be used externally to treat pediatric fever and pityriasis versicolor and orally or intravenously to treat oral thrush in HIV/AIDS patients.

LG treatment for pediatric fever has remarkable clinical efficacy. A total of 120 patients with exogenous fever were selected from the pediatric outpatient clinic of the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, China. Sixty patients in the control group bathed with warm water, and 60 patients in the treatment group bathed with the Zhuang medicine citronella antipyretic external washing formula. The antipyretic time of the control group was (46.46 ± 2.57) h, and that of the treatment group was (36.17 ± 2.21) h. The antipyretic time in the treatment group was significantly shorter than in the control group (Ye et al., 2018).

LG is made into shampoos or creams for Pityriasis versicolor. In the second stage of the study, 47 patients with P. versicolor in the treatment group were administered LGEO, and 29 in the control group were administered ketoconazole. After 40 days of treatment, the cure rate of the mold in the treatment group was 60%, whereas that in the control group was > 80%, both of which had therapeutic effects. It is confirmed that LGEO has antifungal effects and can treat P. versicolor (Carmo, Pereira, Cavalcante, Gayoso, & Lima, 2013).

In addition to external use, LG is administered orally or intravenously to treat oral thrush in patients with HIV/AIDS. In South Africa, 0.5% aqueous gentian violet solution is the first choice in primary care centers to treat oral thrush in patients with HIV. Ninety HIV-positive patients with oral thrush were randomly divided into three treatment groups: gentian violet, lemon juice and LG. In an analysis of the participants who completed the experiment, the therapeutic effects of lemon juice and LG were better than those of gentian violet (Wright et al., 2009).

LG is clinically used to treat epilepsy, anxiety, diabetes, allergies, rheumatism, arthritis, and other diseases. Their clinical applications are illustrated in Fig. 10.

6.3. Daily chemical applications

In addition to its edible and medicinal value, LG is commonly used in skincare products, hair conditioners, mouthwashes, and insecticides because of its unique aroma and properties.

Different concentrations of LGEO (0.5%, 1.0%, and 1.5%, mass ratio) were added to chitosan film-forming matrices to form bioactive skincare films. The concentrations of LGEO strongly controlled the antioxidant properties and water vapor permeability. Chitosan bioactive films containing 0.5% LGEO showed over 70% cell viability, while bioactive films containing 1.5% LGEO with an antioxidant capacity similar to that of N-acetyl-L-cysteine showed activity against Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). LGEO-loaded chitosan biofilms can be used as sheet masks with antioxidant and antibacterial properties for skin care, high elasticity, and selective permeability, and no risk of cytotoxicity (Gaspar et al., 2022).

To evaluate their skincare effects, Unno et al. prepared five LG extracts (80% MeOH, n-hexane, ethyl acetate, butanol and water). LG was found to have anti-aging and whitening effects and significant elastase inhibitory activity. The ethyl acetate extract of LG exhibited the highest elastase inhibitory activity. Elastase breaks down elastin (a fibrin), which can damage skin and cause wrinkling. In addition, LG acts as a tyrosinase inhibitor in treating hyperpigmentation. The ethyl acetate extract exhibited the highest lipase inhibitory activity among the LG extracts. Lipase is one of the main virulence factors in acne and hydrolyzes triglycerides to release free fatty acids. Lipase overexpression improves follicular development and causes acne vulgaris (Unno et al., 2017). Therefore, the less lipase secretes, the less acne there is. Many of these compounds have been reported to have antioxidant activity depending on the composition of LG and have been used as cosmetic ingredients (Sarker & Oba, 2020). Protocatechuic acid is a potential skin antiseptic that induces dose-dependent skin penetration and antibacterial activity against acne in mouse skin (Jalali et al., 2020). These results imply that the EtOAc extract of LG is a promising potential skin care cosmeceutical with activity against acne vulgaris (Kim et al., 2022).

LGEO was added to the conditioner to remove dandruff. LGEO was found to be active against lipophilic yeast, and its efficacy and preference were evaluated. LGEO at 5%, 10% or 15% was added to the base formulation with the highest preference. Subjects used the formulation twice daily and efficacy was assessed on days 7 and 14 using the D-Squame® scale. The results revealed that the use of 5%, 10%, or 15% LGEO conditioners significantly reduced dandruff (P < 0.005) on day 7 (33%, 75%, and 51%, respectively) compared to the blank control, and the effect of reducing dandruff on day 14 (52%, 81%, and 74%, respectively) was more effective (P < 0.005). Thus, LGEO is significantly effective in reducing dandruff, with hair care formulations containing 10% LGEO being the most effective (Chaisripipat et al., 2015).

Owing to its antibacterial properties, LG was manufactured as a mouthwash. The antimicrobial activity of the LG mouthwash against common odor-causing microorganisms was tested using broth microdilution and disc diffusion methods. This randomized, double-blind clinical study included 20 healthy volunteers. Volatile sulfur compound levels were measured in each volunteer using a Halimeter on days 0 and 8. The findings showed that, compared to baseline volatile sulphur compounds (VSCs), VSCs levels were remarkably reduced after using the LG mouthwash for 1 min (50.6%) and 7 d (52.1%), while there was no significant reduction with the placebo. This study illustrated that the LG mouthwash significantly reduced oral odor. This mouthwash may be another option to prevent bad breath, plaque formation and gingivitis (Satthanakul et al., 2015).

LGEO has been developed as an insecticide with good repellency, contact, and fumigation effects. It has outstanding advantages for preventing stored grain, food, and health pests. LGEO has good repellent and fumigation effects on Sitophilus oryzae L., Sitophilus zeamais Motschulsky, Tribolium indicum, Paederus fuscipes Curtis, Anopheles rufus, Aedes albopictus, and Musca domestica L.. Daily chemical applications of LG are shown in Fig. 10.

7. Summary and prospect

As a drug and food homologous medicine, LG was first recorded in the Supplement to Materia Medica with the effects of expelling wind and unblocking collaterals, warming and relieving pain, and draining dampness and diarrhea during the Tang Dynasty (AD 618–907). Phytochemical studies have revealed that LG contains terpenoids, flavonoids, phenolic acids, and other active components. Modern pharmacological studies have shown that LG has many bioactive effects and good development potential, including antibacterial, neuroprotective, hypotensive, hypoglycemic, hypolipidemic, anti-inflammatory, antioxidant, anti-tumor, and other effects for the treatment of pediatric fever, hypertension, stomach disorders, and diabetes. LG is often used as a condiment in food because of its aromatic odor. In the chemical industry, LG is often used to make soaps, detergents, perfumes, skincare products, hair tonics, and mouthwashes. Although the existing research on LG and some of its pharmacodynamic material basis and pharmacological action mechanisms have been elaborated, basic research on action mechanisms and pharmacodynamics is still insufficient and needs further study to facilitate the development and application of LG.

CRediT authorship contribution statement

Xiqin Du: Data curation, Formal analysis, Visualization, Writing – original draft. Meng Zhang: Writing – review & editing. Shuping Wang: Supervision, Writing – review & editing. Jingyang Li: Supervision, Writing – review & editing. Jingze Zhang: Conceptualization, Data curation, Project administration, Validation, Writing – original draft, Writing – review & editing. Dailin Liu: Conceptualization, Data curation, Project administration, Validation, Writing – original draft, Writing – review & editing.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

The work was supported by the National Key R&D Program of China (No. 2022YFC3501805) for financial support. We would like to thank Editage (www.editage.cn) for English language editing.

Contributor Information

Jingze Zhang, Email: zhangjingze1977@163.com.

Dailin Liu, Email: dailinlch@163.com.

References

  1. Arrebola E., Sivakumar D., Bacigalupo R., Korsten L. Combined application of antagonist Bacillus amyloliquefaciens and essential oils for the control of peach postharvest diseases. Crop Protection. 2010;29(4):369–377. [Google Scholar]
  2. Avoseh O., Oyedeji O., Rungqu P., Nkeh-Chungag B., Oyedeji A. Cymbopogon species; Ethnopharmacology, phytochemistry and the pharmacological importance. Molecules. 2015;20(5):7438–7453. doi: 10.3390/molecules20057438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bahri S., Jameleddine S., Shlyonsky V. Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms. Biomedicine & Pharmacotherapy. 2016;84:569–582. doi: 10.1016/j.biopha.2016.09.067. [DOI] [PubMed] [Google Scholar]
  4. Bakkali F., Averbeck S., Averbeck D., Idaomar M. Biological effects of essential oils–a review. Food and Chemical Toxicology. 2008;46(2):446–475. doi: 10.1016/j.fct.2007.09.106. [DOI] [PubMed] [Google Scholar]
  5. Bao X.L., Yuan H.H., Wang C.Z., Fan W., Lan M.B. Polysaccharides from Cymbopogon citratus with antitumor and immunomodulatory activity. Pharmaceutical Biology. 2015;53(1):117–124. doi: 10.3109/13880209.2014.911921. [DOI] [PubMed] [Google Scholar]
  6. Barbosa L.C., Pereira U.A., Martinazzo A.P., Maltha C.R., Teixeira R.R., Melo Ede C. Evaluation of the chemical composition of Brazilian commercial Cymbopogon citratus (D.C.) stapf samples. Molecules. 2008;13(8):1864–1874. doi: 10.3390/molecules13081864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bertea C.M., Maffei M.E. The Genus Cymbopogon botany, including anatomy, physiology, biochemistry, and molecular biology. Essential Oil-Bearing Grasses: The genus Cymbopogon. 2010:1–24. [Google Scholar]
  8. Blanco M.M., Costa C.A., Freire A.O., Santos J.G., Jr., Costa M. Neurobehavioral effect of essential oil of Cymbopogon citratus in mice. Phytomedicine. 2009;16(2–3):265–270. doi: 10.1016/j.phymed.2007.04.007. [DOI] [PubMed] [Google Scholar]
  9. Borges P.H.O., Pedreiro S., Baptista S.J., Geraldes C., Batista M.T., Silva M.M.C., Figueirinha A. Inhibition of alpha-glucosidase by flavonoids of Cymbopogon citratus (DC) Stapf. Journal of Ethnopharmacology. 2021;280 doi: 10.1016/j.jep.2021.114470. [DOI] [PubMed] [Google Scholar]
  10. Campos C.A., Lima B.S., Trindade G.G., Souza E.P., Mota D.S., Heimfarth L.…Sarmento V.H. Anti-hyperalgesic and anti-inflammatory effects of citral with β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes in animal models. Life Sciences. 2019;229:139–148. doi: 10.1016/j.lfs.2019.05.026. [DOI] [PubMed] [Google Scholar]
  11. Campos J., Schmeda-Hirschmann G., Leiva E., Guzman L., Orrego R., Fernandez P.…Aguayo C. Lemon grass (Cymbopogon citratus (D.C) Stapf) polyphenols protect human umbilical vein endothelial cell (HUVECs) from oxidative damage induced by high glucose, hydrogen peroxide and oxidised low-density lipoprotein. Food Chemistry. 2014;151:175–181. doi: 10.1016/j.foodchem.2013.11.018. [DOI] [PubMed] [Google Scholar]
  12. Carbajal D., Casaco A., Arruzazabala L., Gonzalez R., Tolon Z. Pharmacological study of Cymbopogon citratus leaves. Journal of Ethnopharmacology. 1989;25(1):103–107. doi: 10.1016/0378-8741(89)90049-4. [DOI] [PubMed] [Google Scholar]
  13. Carmo E.S., Pereira F.d.O., Cavalcante N.M., Gayoso C.W., Lima E.D.O. Treatment of pityriasis versicolor with topical application of essential oil of Cymbopogon citratus (DC) Stapf-therapeutic pilot study. Anais Brasileiros de Dermatologia. 2013;88:381–385. doi: 10.1590/abd1806-4841.20131800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chaisripipat W., Lourith N., Kanlayavattanakul M. Anti-dandruff hair tonic containing lemongrass (Cymbopogon flexuosus) oil. Forschende Komplementärmedizin. 2015;22(4):226–229. doi: 10.1159/000432407. [DOI] [PubMed] [Google Scholar]
  15. Cheel J., Theoduloz C., Rodríguez J., Schmeda-Hirschmann G. Free radical scavengers and antioxidants from Lemongrass (Cymbopogon citratus (DC.) Stapf.) Journal of Agricultural and Food Chemistry. 2005;53(7):2511–2517. doi: 10.1021/jf0479766. [DOI] [PubMed] [Google Scholar]
  16. Chen Y., Qiao S., Liu H., Xing H., Chen P. Structural characterization and anti-breast cancer activity in vitro of a novel polysaccharide from Cymbopogon citratus. Frontiers in Nutrition. 2022;9 doi: 10.3389/fnut.2022.911838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dagupen, M. K. T., Januszewska, R., Lino, L. L., Tagarino, D., Viaene, J., Arguelles, R., & Bautista, R. (2009). Consumer behavior towards lemongrass (Cymbopogon citratus) tea in Benguet province, Northern Philippines. BANWA: A Multidisciplinary Journal, 6(1774−2016−141633), 1−12.
  18. Crawford M., Hanson S.W., Koker M.E. The structure of Cymbopogone, a novel triterpenoid from lemongrass. Tetrahedron Letters. 1975;16(35):3099–3102. [Google Scholar]
  19. Deng B., Yang B., Chen J., Wang S., Zhang W., Guo Y.…Li B. Gallic acid induces T-helper-1-like treg cells and strengthens immune checkpoint blockade efficacy. Journal for Immunotherapy of Cancer. 2022;10(7) doi: 10.1136/jitc-2021-004037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Editorial board of Chinese Materia Medica of National Administration of Traditional Chinese Medicine of the People’s Republic of China Chinese Materia Medica. Shanghai Scientific & Technical Publishers. 1999;8 [Google Scholar]
  21. Ekpenyong C.E., Akpan E., Nyoh A. Ethnopharmacology, phytochemistry, and biological activities of Cymbopogon citratus (DC.) Stapf extracts. Chinese Journal of Natural Medicines. 2015;13(5):321–337. doi: 10.1016/S1875-5364(15)30023-6. [DOI] [PubMed] [Google Scholar]
  22. Elekofehinti O.O., Onunkun A.T., Olaleye T.M. Cymbopogon citratus (DC.) Stapf mitigates ER-stress induced by streptozotocin in rats via down-regulation of GRP78 and up-regulation of Nrf2 signaling. Journal of Ethnopharmacology. 2020;262 doi: 10.1016/j.jep.2020.113130. [DOI] [PubMed] [Google Scholar]
  23. Ewenighi C.O., Dimkpa U., Adejumo B.I., Onyeanusi J.C., Onoh L.U., Ezeugwu U.…Anojulu A. Estimation of lipid profile and glucose level in alloxan-induced diabetic rats treated with Cymbopogon citratus (lemongrass) Journal of Experimental & Integrative Medicine. 2013;3(3):249–253. [Google Scholar]
  24. Francisco V., Costa G., Figueirinha A., Marques C., Pereira P., Neves B.M.…Batista M.T. Anti-inflammatory activity of Cymbopogon citratus leaves infusion via proteasome and nuclear factor-κB pathway inhibition: Contribution of chlorogenic acid. Journal of Ethnopharmacology. 2013;148(1):126–134. doi: 10.1016/j.jep.2013.03.077. [DOI] [PubMed] [Google Scholar]
  25. Francisco V., Figueirinha A., Neves B.M., García-Rodríguez C., Lopes M.C., Cruz M.T., Batista M.T. Cymbopogon citratus as source of new and safe anti-inflammatory drugs: Bio-guided assay using lipopolysaccharide-stimulated macrophages. Journal of Ethnopharmacology. 2011;133(2):818–827. doi: 10.1016/j.jep.2010.11.018. [DOI] [PubMed] [Google Scholar]
  26. Gaspar A.L., Gaspar A.B., Contini L.R.F., Silva M.F., Chagas E.G.L., Bahu J.O.…Yoshida C.M.P. Lemongrass (Cymbopogon citratus)-incorporated chitosan bioactive films for potential skincare applications. International Journal of Pharmaceutics. 2022;628 doi: 10.1016/j.ijpharm.2022.122301. [DOI] [PubMed] [Google Scholar]
  27. Ghorbani A. Mechanisms of antidiabetic effects of flavonoid rutin. Biomedicine & Pharmacotherapy. 2017;96:305–312. doi: 10.1016/j.biopha.2017.10.001. [DOI] [PubMed] [Google Scholar]
  28. Goncalves E.C.D., Assis P.M., Junqueira L.A., Cola M., Santos A.R.S., Raposo N.R.B., Dutra R.C. Citral inhibits the inflammatory response and hyperalgesia in mice: The role of TLR4, TLR2/Dectin-1, and CB2 cannabinoid receptor/ATP-sensitive K+ channel pathways. Journal of Natural Products. 2020;83(4):1190–1200. doi: 10.1021/acs.jnatprod.9b01134. [DOI] [PubMed] [Google Scholar]
  29. Hacke A.C.M., da Silva F.D.A., Lima D., Vellosa J.C.R., Rocha J.B.T., Marques J.A., Pereira R.P. Cytotoxicity of Cymbopogon citratus (DC) Stapf fractions, essential oil, citral, and geraniol in human leukocytes and erythrocytes. Journal of Ethnopharmacology. 2022;291 doi: 10.1016/j.jep.2022.115147. [DOI] [PubMed] [Google Scholar]
  30. Hacke A.C.M., Miyoshi E., Marques J.A., Pereira R.P. Cymbopogon citratus (DC.) Stapf, citral and geraniol exhibit anticonvulsant and neuroprotective effects in pentylenetetrazole-induced seizures in zebrafish. Journal of Ethnopharmacology. 2021;275 doi: 10.1016/j.jep.2021.114142. [DOI] [PubMed] [Google Scholar]
  31. Imran M., Rauf A., Abu-Izneid T., Nadeem M., Shariati M.A., Khan I.A.…Mubarak M.S. Luteolin, a flavonoid, as an anticancer agent: A review. Biomedicine Pharmacotherapy. 2019;112 doi: 10.1016/j.biopha.2019.108612. [DOI] [PubMed] [Google Scholar]
  32. Jalali O., Best M., Wong A., Schaeffer B., Bauer B., Johnson L. Protocatechuic acid as a topical antimicrobial for surgical skin antisepsis: Preclinical investigations. JBJS Open Access. 2020;5(3) doi: 10.2106/JBJS.OA.19.00079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Khan F.A., Maalik A., Murtaza G. Inhibitory mechanism against oxidative stress of caffeic acid. Journal of Food and Drug Analysis. 2016;24(4):695–702. doi: 10.1016/j.jfda.2016.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Khan M.S., Ahmad I. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans. Journal of Ethnopharmacology. 2012;140(2):416–423. doi: 10.1016/j.jep.2012.01.045. [DOI] [PubMed] [Google Scholar]
  35. Kim C., Park J., Lee H., Hwang D.Y., Park S.H., Lee H. Evaluation of the EtOAc extract of lemongrass (Cymbopogon citratus) as a potential skincare cosmetic material for acne vulgaris. Journal of Microbiology and Biotechnology. 2022;32(5):594–601. doi: 10.4014/jmb.2201.01037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kim D.H., Park K.W., Chae I.G., Kundu J., Kim E.H., Kundu J.K., Chun K.S. Carnosic acid inhibits STAT3 signaling and induces apoptosis through generation of ROS in human colon cancer HCT116 cells. Molecular Carcinogenesis. 2016;55(6):1096–1110. doi: 10.1002/mc.22353. [DOI] [PubMed] [Google Scholar]
  37. Koba K., Sanda K., Guyon C., Raynaud C., Chaumont J.P., Nicod L. In vitro cytotoxic activity of Cymbopogon citratus L. and Cymbopogon nardus L. essential oils from Togo. Bangladesh Journal of Pharmacology. 2008;4(1):29–34. [Google Scholar]
  38. Kouame N.M., Kamagate M., Koffi C., Die-Kakou H.M., Yao N.A.R., Kakou A. Cymbopogon citratus (DC.) Stapf: Ethnopharmacologie, phytochimie, activités pharmacologiques et toxicologie. Phytothérapie. 2015;14(6):384–392. [Google Scholar]
  39. Kpoviessi S., Bero J., Agbani P., Gbaguidi F., Kpadonou-Kpoviessi B., Sinsin B.…Quetin-Leclercq J. Chemical composition, cytotoxicity and in vitro antitrypanosomal and antiplasmodial activity of the essential oils of four Cymbopogon species from Benin. Journal of Ethnopharmacology. 2014;151(1):652–659. doi: 10.1016/j.jep.2013.11.027. [DOI] [PubMed] [Google Scholar]
  40. Leite J., Maria De Lourdes V.S., Maluf E., Assolant K., Suchecki D., Tufik S.…Carlini E. Pharmacology of lemongrass (Cymbopogon citratus Stapf). III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. Journal of Ethnopharmacology. 1986;17(1):75–83. doi: 10.1016/0378-8741(86)90074-7. [DOI] [PubMed] [Google Scholar]
  41. Li, C., Luo, Y., Zhang, W., Cai, Q., Wu, X., Tan, Z., Chen, R., Chen, Z., Wang, S., & Zhang, L. (2021). A comparative study on chemical compositions and biological activities of four essential oils: Cymbopogon citratus (DC.) Stapf, Cinnamomum cassia (L.) Presl, Salvia japonica Thunb. and Rosa rugosa Thunb. Journal of Ethnopharmacology, 280, 114472. [DOI] [PubMed]
  42. Li D., Rui Y.X., Guo S.D., Luan F., Liu R., Zeng N. Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives. Life Sciences. 2021;284 doi: 10.1016/j.lfs.2021.119921. [DOI] [PubMed] [Google Scholar]
  43. Lorenzetti B.B., Souza G.E., Sarti S.J., Santos Filho D., Ferreira S.H. Myrcene mimics the peripheral analgesic activity of lemongrass tea. Journal of Ethnopharmacology. 1991;34(1):43–48. doi: 10.1016/0378-8741(91)90187-i. [DOI] [PubMed] [Google Scholar]
  44. Madi Y.F., Choucry M.A., El-Marasy S.A., Meselhy M.R., El-Kashoury E.A. UPLC-Orbitrap HRMS metabolic profiling of Cymbopogon citratus cultivated in Egypt; neuroprotective effect against AlCl3-induced neurotoxicity in rats. Journal of Ethnopharmacology. 2020;259 doi: 10.1016/j.jep.2020.112930. [DOI] [PubMed] [Google Scholar]
  45. Meabed E.M.H., Abou-Sreea A.I.B., Roby M.H.H. Chemical analysis and giardicidal effectiveness of the aqueous extract of Cymbopogon citratus Stapf. Parasitology Research. 2018;117(6):1745–1755. doi: 10.1007/s00436-018-5855-1. [DOI] [PubMed] [Google Scholar]
  46. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacological Reviews. 2000;52(4):673–751. [PubMed] [Google Scholar]
  47. Moreira F.V., Bastos J.F.A., Blank A.F., Alves P.B., Santos M. R.V. Chemical composition and cardiovascular effects induced by the essential oil of Cymbopogon citratus DC. Stapf, Poaceae, in rats. Revista Brasileira de Farmacognosia. 2010;20(6):904–909. [Google Scholar]
  48. Niu B., Jin C., Liang J., Shang R., Hao B., Wang X.…Liu Y. Chemical constituents and antibacterial activities of essential oils of origanum, citronella and clove in vitro. Food Research and Development. 2020;41(3):46–52. [Google Scholar]
  49. Oladeji O.S., Adelowo F.E., Ayodele D.T., Odelade K.A. Phytochemistry and pharmacological activities of Cymbopogon citratus: A review. Scientific African. 2019;6:e00137. [Google Scholar]
  50. OuYang Q., Liu Y., Oketch O.R., Zhang M., Shao X., Tao N. Citronellal exerts its antifungal activity by targeting ergosterol biosynthesis in Penicillium digitatum. Journal of Fungi (Basel) 2021;7(6):432. doi: 10.3390/jof7060432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. OuYang T., Yang Q., Yan H., Xia X., Wang D., Wang S. Research progress in volatile oil of Cymbopogon citratus (DC.) Stapf. Chinese Journal of Information on Traditional Chinese Medicine. 2016;23(2):130–133. [Google Scholar]
  52. Pereira S.L., Marques A.M., Sudo R.T., Kaplan M.A., Zapata-Sudo G. Vasodilator activity of the essential oil from aerial parts of Pectis brevipedunculata and its main constituent citral in rat aorta. Molecules. 2013;18(3):3072–3085. doi: 10.3390/molecules18033072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Qiu S., Lin B., Zhang S., Zhang S., Hong J., Zheng K. Research advance on application of Cymbopogon in food. The Food Industry. 2020;41(9):276–279. [Google Scholar]
  54. Ruvinov I., Nguyen C., Scaria B., Vegh C., Zaitoon O., Baskaran K.…Pandey S. Lemongrass extract possesses potent anticancer activity against human colon cancers, inhibits tumorigenesis, enhances efficacy of FOLFOX, and reduces its adverse effects. Integrative Cancer Therapies. 2019;18 doi: 10.1177/1534735419889150. 1534735419889150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Sagradas J., Costa G., Figueirinha A., Castel-Branco M.M., Cabrita A.M.S., Figueiredo I.V., Batista M.T. Gastroprotective effect of Cymbopogon citratus infusion on acute ethanol-induced gastric lesions in rats. Journal of Ethnopharmacology. 2015;173:134–138. doi: 10.1016/j.jep.2015.07.001. [DOI] [PubMed] [Google Scholar]
  56. Sahal G., Woerdenbag H.J., Hinrichs W.L.J., Visser A., Tepper P.G., Quax W.J.…Bilkay I.S. Antifungal and biofilm inhibitory effect of Cymbopogon citratus (lemongrass) essential oil on biofilm forming by Candida tropicalis isolates: An in vitro study. Journal of Ethnopharmacology. 2020;246 doi: 10.1016/j.jep.2019.112188. [DOI] [PubMed] [Google Scholar]
  57. Santos Serafim Machado, M., Ferreira Silva, H. B., Rios, R., Pires de Oliveira, A., Vilany Queiroz Carneiro, N., Santos Costa, R., Santos Alves, W., Meneses Souza, F. L., da Silva Velozo, E., Alves de Souza, S., Sarmento Silva, T. M., Silva, M. L., Pontes-de-Carvalho, L. C., Alcantara-Neves, N. M., & Figueiredo, C. A. (2015). The anti-allergic activity of Cymbopogon citratus is mediated via inhibition of nuclear factor kappa B (Nf-Kappab) activation. BMC Complementary and Alternative Medicine, 15, 168. [DOI] [PMC free article] [PubMed]
  58. Sarker U., Oba S. Polyphenol and flavonoid profiles and radical scavenging activity in leafy vegetable Amaranthus gangeticus. BMC Plant Biology. 2020;20(1):499. doi: 10.1186/s12870-020-02700-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Satthanakul P., Taweechaisupapong S., Paphangkorakit J., Pesee M., Timabut P., Khunkitti W. Antimicrobial effect of lemongrass oil against oral malodour micro-organisms and the pilot study of safety and efficacy of lemongrass mouthrinse on oral malodour. Journal of Applied Microbiology. 2015;118(1):11–17. doi: 10.1111/jam.12667. [DOI] [PubMed] [Google Scholar]
  60. Shen P., Lin W., Deng X., Ba X., Han L., Chen Z.…Tu S. Potential implications of quercetin in autoimmune diseases. Frontiers in Immunology. 2021;12 doi: 10.3389/fimmu.2021.689044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Tapia A., Cheel J., Theoduloz C., Rodríguez J., Schmeda-Hirschmann G., Gerth A.…Gomez-Kosky R. Free radical scavengers from Cymbopogon citratus (DC.) stapf plants cultivated in bioreactors by the temporary immersion (TIS) principle. Zeitschrift für Naturforschung C. 2007;62(5–6):447–457. doi: 10.1515/znc-2007-5-620. [DOI] [PubMed] [Google Scholar]
  62. Thangam R., Sathuvan M., Poongodi A., Suresh V., Pazhanichamy K., Sivasubramanian S.…Kannan S. Activation of intrinsic apoptotic signaling pathway in cancer cells by Cymbopogon citratus polysaccharide fractions. Carbohydrate Polymers. 2014;107:138–150. doi: 10.1016/j.carbpol.2014.02.039. [DOI] [PubMed] [Google Scholar]
  63. Thangam R., Suresh V., Kannan S. Optimized extraction of polysaccharides from Cymbopogon citratus and its biological activities. International Journal Biological Macromolecules. 2014;65:415–423. doi: 10.1016/j.ijbiomac.2014.01.033. [DOI] [PubMed] [Google Scholar]
  64. Uchida, N. S., Silva-Filho, S. E., Aguiar, R. P., Wiirzler, L. A. M., Cardia, G. F. E., Cavalcante, H. A. O., Silva-Comar, F. M. d. S., Becker, T. C. A., Silva, E. L., & Bersani-Amado, C. A. (2017). Protective effect of Cymbopogon citratus essential oil in experimental model of acetaminophen-induced liver injury. The American Journal of Chinese Medicine, 45(3), 515−532. [DOI] [PubMed]
  65. Tyagi A.K., Malik A. Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: Microscopic observations and chemical characterization of Cymbopogon citratus. BMC Complementary and Alternative Medicine. 2010;10(1):65. doi: 10.1186/1472-6882-10-65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Umukoro S., Ben-Azu B., Ajayi A.M., Adebesin A., Emokpae O. Cymbopogon citratus aqueous leaf extract attenuates neurobehavioral and biochemical changes induced by social defeat stress in mice. Chinese Herbal Medicines. 2020;12(3):303–309. doi: 10.1016/j.chmed.2020.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Unno M., Cho O., Sugita T. Inhibition of propionibacterium acnes lipase activity by the antifungal agent ketoconazole. Microbiology and Immunology. 2017;61(1):42–44. doi: 10.1111/1348-0421.12464. [DOI] [PubMed] [Google Scholar]
  68. Venzon L., Mariano L.N.B., Somensi L.B., Boeing T., de Souza P., Wagner T.M.…da Silva L.M. Essential oil of Cymbopogon citratus (lemongrass) and geraniol, but not citral, promote gastric healing activity in mice. Biomedicine & Pharmacotherapy. 2018;98:118–124. doi: 10.1016/j.biopha.2017.12.020. [DOI] [PubMed] [Google Scholar]
  69. Wright S., Maree J., Sibanyoni M. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine. 2009;16(2–3):118–124. doi: 10.1016/j.phymed.2008.07.015. [DOI] [PubMed] [Google Scholar]
  70. Xiang J.M., Wei J.H., Xu L.J., Xiao P.G. Research progress in Cymbopogon citratus (DC.) Stapf and lemongrass tea. Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology. 2017;19(5):874–879. [Google Scholar]
  71. Yang H., Huang X., Pan L., Shi Y., Ye B., Ding H., Li Y. Antibacterial and antioxidant activities of citronella essential oil. Subtropical Plant Science. 2021;50(2):92–95. [Google Scholar]
  72. Yang M., Zhao L., Gu S., Zheng Z., He S. Research progress on chemical constituents and pharmacological effects of citronella. Chinese Traditional Patent Medicine. 2020;42(3):714–719. [Google Scholar]
  73. Ye Y., Nong Z., Wei X., Shan L., Zou M., Guo C., Wang L. Antifebrile effect on infantile exogenous fever treated with Zhuang medicine Citronella antipyretic external washing agent. Journal of Liaoning University of Traditional Chinese Medicine. 2018;20(11):45–48. [Google Scholar]
  74. Zhang M., Sun L., Li C., Gao W., Yang J., Wang A.…Ji T. A new lanostane-type triterpenoid from Cymbopogon citratus. China Journal of Chinese Materia Medica. 2014;39(10):1834–1837. [PubMed] [Google Scholar]

Articles from Chinese Herbal Medicines are provided here courtesy of Elsevier

RESOURCES